top of page

Annual International Congress in Liquid Biopsy, aiding the fight against cancer.


Bristol - July 4th, 2019. We are pleased to announce the partnership between ISLB (International Society of Liquid Biopsy) and Lacort Medical, offering advances in clinical oncology, in the use of liquid biopsies as new
clinical tools by means of academic activities, training and education to the international medical community with a multidisciplinary approach.

Lacort Medical will work with the International Society of Liquid Biopsy to design the online programs and to implement a roadmap of academic activities. This will include international congresses, workshops, webinars,
and digital activities. Lacort Medical will also provide dissemination support to the ISLB in different pathologies aiming to improve the professional development of the international medical community.

Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for costly or invasive procedures. Precision medicine has dramatically improved the field of medical oncology; and the introduction of patient-tailored therapies has significantly improved all measurable outcomes.


In what will undoubtedly be one of the most comprehensive initiatives in Liquid Biopsy aiding the fight against cancer, the ISLB and Lacort Medical are pleased to announce the Annual International Congress ISLB in
Liquid Biopsy,
which will take place in Barcelona on April 3-4, 2020. This meeting will bring together experts in the field of Liquid Biopsy who will share their latest advances in their clinical field. During the event, clinical
best practices related to liquid biopsy will be presented, new consensus will be reached and the latest advances in cellular and molecular diagnostic technologies will be discussed.


The ISLB was founded in 2017 in the city of Granada, Spain, with the main objective to introduce the use of liquid biopsies as a new clinical tool, connecting professionals with diverse experience and medical background in precision medicine, utilizing education and information resources to support advancements on liquid biopsy technologies.

Lacort Medical, based in England United Kingdom, provides healthcare professionals (doctors, residents, technicians and students) with academic tools and communication channels through the implementation of courses, scientific symposiums, congresses, and prevention projects in different pathologies.


Lacort Medical aims to reach and to improve healthcare professionals worldwide through the dissemination of regional research, and integrating the medical community by offering a unique networking platform with a multidisciplinary approach.

bottom of page